Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • MANAGEMENT OF LATENT TUBERCULOSIS INFECTION BASED ON T-SPOT.TB ASSAY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

    Emrah Kiliacaslan, Kadir Canoglu
    e2023003
    2022-12-31
    https://doi.org/10.4084/MJHID.2023.003
    1401
    PDF: 1105
    HTML: 463
  • TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin

    Cristina Papayannidis, Vincenzo Federico, Luana Fianchi, Patrizia Pregno, Novella Pugliese, Alessandra Romano, Federica Irene Grifoni
    e2022073
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.073
    1213
    PDF: 973
    HTML: 200
  • IMPACT OF RED CELL EXCHANGE TRANSFUSION ON INFLAMMATORY MARKERS IN SICKLE CELL DISEASE

    Adriana Costa, Inês Mendes, Joana Lage, Marta Moniz, Catarina Amorim, Pedro Nunes, Helena Almeida, Carlos Escobar, Ana Ventura, Teresa Ferreira
    e2025011
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.011
    1941
    PDF: 1321
    HTML: 216
  • Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma

    Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti
    e2025051
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.051
    718
    PDF: 567
    HTML: 24
  • OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT

    Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst
    e2023025
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.025
    1279
    HTML: 296
    PDF: 927
    Suppl. Files: 442
  • HHVs AND LYMPHOPROLIFERATIVE DISORDERS

    C Quadrelli, P Barozzi, G Riva, Mario Luppi
    e2011043
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.043
    1369
    PDF: 814
    HTML: 3113
  • LIVER DISEASE & SICKLE CELL DISEASE: AUTOIMMUNE HEPATITIS MORE THAN A COINCIDENCE; A SYSTEMATIC LITERATURE REVIEW.

    Kelvin Lynch, Andrea Mega, Andrea Piccin, Massimo Daves, Helen Fogarty
    e2023060
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.060
    2141
    PDF: 981
    HTML: 234
  • CHARACTERISTICS OF PATIENTS HOSPITALIZED WITH 2009 H1N1 INFLUENZA IN A TERTIARY CARE HOSPITAL IN SOUTHERN SAUDI ARABIA

    Adnan Agha, Abdul Qader Alrawi, Abdelhaleem Bella, Mohammed S. AlAyed
    e2012002
    2012-01-16
    https://doi.org/10.4084/mjhid.2012.002
    1226
    PDF: 659
    HTML: 809
  • PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON

    Abdel Badih El Ariss, Mohamad Younes, Jad Matar, Zeina Berjaoui
    e2016015
    2016-02-20
    https://doi.org/10.4084/mjhid.2016.015
    4083
    PDF: 1003
    HTML: 19152
  • ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Murat Akova
    e2017002
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.002
    4054
    PDF: 1230
    HTML: 1948
    Table 1: 191
  • TREATMENT WITH LOW-DOSE CYTARABINE IN ELDERLY PATIENTS (AGE 70 YEARS OR OLDER) WITH ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION EXPERIENCE

    Maël Heiblig, Mohamed Elhamri, Isabelle Tigaud, Adriana Plesa, Fiorenza Barraco, Hélène Labussière, Sophie Ducastelle, Mauricette Michallet, Franck Nicolini, Claudiu Plesa, Eric Wattel, Gilles Salles, Xavier Thomas
    e2016009
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.009
    7285
    PDF: 1483
    HTML: 1638
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 2- FOCUS ON THERAPY

    Michele Bibas, Shayna Sarosiek , Jorge Castillo
    e2025015
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.015
    2473
    PDF: 1973
    HTML: 196
  • GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE

    Francesco Fabozzi, Angela Mastronuzzi
    e2023032
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.032
    1893
    PDF: 501
    HTML: 526
  • LIGHT CHAIN AMYLOIDOSIS

    Paolo Milani, Giampaolo Merlini, Giovanni Palladini
    e2018022
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.022
    5490
    PDF: 2308
    HTML: 1324
  • The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients

    Shuku Sato
    e2025070
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.070
    1014
    PDF: 369
    HTML: 86
  • DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE

    Zeno Bisoffi, Federico Gobbi, Dora Buonfrate, Jef Van den Ende
    e2012036
    2012-05-09
    https://doi.org/10.4084/mjhid.2012.036
    3580
    PDF: 1105
    HTML: 23328
  • COMPARISON OF THE POWER OF PROCALCITONIN AND C-REACTIVE PROTEIN TO DISCRIMINATE BETWEEN DIFFERENT AETIOLOGIES OF FEVER IN PROLONGED PROFOUND NEUTROPENIA: A SINGLE-CENTRE PROSPECTIVE OBSERVATIONAL STUDY.

    Anke Verlinden, Veronique De Vroey, Herman Goossens, Ella Roelant, Ann Van de Velde, Zwi Berneman, Wilfried Schroyens, Alain Gadisseur
    e2019023
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.023
    6733
    PDF: 1073
    HTML: 354
  • Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited

    IOANNIS KOTSIANIDIS
    e2019045
    2019-06-25
    https://doi.org/10.4084/mjhid.2019.045
    1075
    PDF: 838
    HTML: 234
  • CLINICAL FEATURES AND CLINICAL OUTCOME OF ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS TREATED AT CAIRO NATIONAL CANCER INSTITUTE IN EGYPT

    Ola Khorshid, Amira Diaa, Mohamed Abd El Moaty, Rafat Abd El Fatah, Ihab El Dessouk, Maha Abd El Hamid, Essam El Noshokaty, Ghada El Saied, Tamer M Fouad, Safaa M Ramadan
    e2011060
    2011-12-07
    https://doi.org/10.4084/mjhid.2011.060
    3004
    PDF: 937
    HTML: 2285
  • NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis

    alvisa palese, chiara visintini, margherita venturini, gianpaolo gargiulo, stefano botti
    e2019051
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.051
    1835
    PDF: 1043
    HTML: 231
  • ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS

    Lourdes Vazquez
    e2016040
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.040
    4265
    PDF: 1366
    HTML: 2033
  • DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

    Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso
    e2022030
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.030
    1349
    HTML: 385
    PDF: 812
  • Isavuconazole therapy of disseminated and encephalic Saprochaete capitata infection in an acute myeloid leukemia patient treated with midostaurin.

    Salvatore Perrone, Chiara Lisi, Elettra Ortu La Barbera, Cristina Luise, Miriam Lichtner, Corrado Girmenia, Giuseppe Cimino
    e2020026
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.026
    1417
    PDF: 800
    HTML: 312
  • OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES

    Jon Salmanton-Garcia, Francesco Marchesi, Oliver A. Cornely, Jannik Stemler, Pierantonio Menna
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.022
    967
    PDF: 1139
    Suppl. Files: 142
    HTML: 66
  • THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.

    Ugo Testa, Giuseppe Leone, Prof. M.D. Cappellini
    e2024068
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.068
    2092
    PDF: 1257
    Html: 274
  • The COST-UTILITY ANALYSIS OF FOUR CHELATION REGIMENS FOR ?-THALASSEMIA MAJOR: A CHINESE PERSPECTIVE

    Jialian Li
    e2020029
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.029
    1717
    PDF: 963
    HTML: 267
  • CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

    Ahmet Yigitbasi, Elif Gulsum Umit, Ufuk Demirci, Guray Aygun, Nese Varli, Elif Aksoy, Fehmi Hindilerden, Emine Gulturk, Eren Arslan Davulcu, Ahmet Muzaffer Demir
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.027
    643
    PDF: 410
    HTML: 68
  • CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

    Juliana Maria Camargos Rocha, Sandra Guerra Xavier, Marcelo Eduardo Lima Souza, Juliana Godoy Assumpção, Mitiko Murao, Benigna Maria Oliveira
    e2016024
    2016-04-10
    https://doi.org/10.4084/mjhid.2016.024
    4541
    PDF: 1326
    HTML: 4609
  • THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML

    Dr. Palmieri, Ilaria Del Principe, Dr. Maurillo, Prof. Venditti, Francesco Buccisano
    e2023051
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.051
    1581
    PDF: 800
    HTML: 157
  • Seven-Year Course of Hypoplastic Myelodysplastic Syndrome Unmasked by Secondary and Neurosyphilis.

    Ali Turunç, Hüseyin Derya Dinçyürek, Birol Güvenç
    e2026026
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.026
    455
    PDF: 297
    HTML: 82
  • HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT

    Anna Locasciulli, Barbara Montante, Emanuela Morelli, Virginia Gulino, Anna Proia, Maria Beatrice Pinazzi
    e2009016
    https://doi.org/10.4084/mjhid.2009.016
    960
    PDF: 530
    HTML: 719
  • NEW STRATEGIES FOR STEM CELL MOBILIZATION

    Roberto Lemoli
    e2012066
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.066
    2374
    PDF: 848
    HTML: 2450
  • THE IMPACT OF PRE-ANALYTICAL FACTORS ON BLOOD GLUCOSE MEASUREMENTS AND  and recommendations THE IMPACT OF PRE-ANALYTICAL FACTORS ON BLOOD GLUCOSE MEASUREMENTS AND RECOMMENDATIONS  FOR CLINICAL PRACTICE: AN ICET-A MULTICENTER SURVEY IN TRANSFUSION-DEPENDENT Β THALASSEMIA (Β-TDT) PATIENTS

    Vincenzo De Sanctis, Christos Kattamis, Duran Canatan, Defne Ay Tuncel, Sule Unal , Dulani Kottahachchi, Mohamed A Yassin, Ashraf T Soliman, Saif Al Yaarubi , Yasser Wali, Mehran Karimi, Forough Saki, Mohammad Faranoush, Polyxeni Delaporta, Antonis Kattamis, Iskra Modeva, Ploutarchos Tzoulis, Shahina Daar, Irene Savvidou
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.035
    163
    PDF: 160
    HTML: 11
  • SICKLE CELL TRAIT, CLINICAL MANIFESTATIONS AND OUTCOMES: A CROSS-SECTIONAL STUDY

    Diego A Vargas-Hernández, Adriana Catalina Uscategui-Ruiz, Andrés Jesus Prada-Rueda , Consuelo Romero-Sánchez
    e2023015
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.015
    1632
    PDF: 1082
    HTML: 474
  • COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis

    Vahibe Aydın Sarıkaya, gülşah Tunçer, sevim Özdemir, Rüştü Türkay, Burak Sarıkaya, Saime Gül Barut, Esen Gül Uzuner, Filiz Pehlivanoğlu
    e2025078
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.078
    520
    PDF: 282
    Html: 23
  • COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

    Jean Elcheikh
    e2015048
    2015-08-21
    https://doi.org/10.4084/mjhid.2015.048
    1873
    PDF: 1005
    HTML: 1330
  • West Nile Virus Encephalitis in A Patient with Chronic Lymphocytic Leukemia

    Giovanni D'Arena, Carmela Palladino, Michele Bosco, Michele Gambardella
    e2025010
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.010
    1347
    PDF: 1087
    HTML: 155
  • REAL WORLD DATA ON CHARACTERISTICS AND MANAGEMENT OF COMMUNITY PATIENTS RECEIVING ANTICOAGULATION THERAPY WHO PRESENTED WITH ACUTE BLEEDING TO THE EMERGENCY DEPARTMENT AT A REGIONAL AUSTRALIAN HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY. Anticoagulation and bleeding ?

    Fayez Hanna, Annemarie Hyppa, Ajay Prakash, Usira Vithanarachchi, Hizb U Dawar, Zar Sanga, George Olabode, Hamish Crisp, Professor Alhossain A. Khalafallah
    e2021017
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.017
    1557
    PDF: 534
    HTML: 308
  • POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

    Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles
    e2010016
    2010-06-19
    https://doi.org/10.4084/mjhid.2010.016
    1156
    PDF: 736
    HTML: 575
  • SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY

    Ivan GUR, Roei Tounek, Yaniv Dotan, Elite Vainer Evgrafov, Stav Rakedzon, Eyal Fuchs
    e2024006
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.006
    1135
    PDF: 1286
    HTML: 177
  • RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM

    Ugo Testa, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2023062
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.062
    1175
    PDF: 1058
    HTML: 187
  • Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio

    Dr. Enrica A. Martino, Dr. G. Mele, Dr. F. Morabito, Dr. M. Gentile, Dr. E. Vigna
    e2025006
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.006
    2143
    PDF: 1567
    HTML: 258
  • MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY

    Emanuele Angelucci, Silvana Anna Maria Urru, Federica Pilo, Alberto Piperno
    e2017021
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.021
    3350
    PDF: 1286
    HTML: 1856
    Fig.1: 196
    Fig. 2: 199
  • OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE

    Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, Miriam Isola, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi
    e2010010
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.010
    1485
    PDF: 769
    HTML: 758
  • EXPRESSION AND CLINICAL CORRELATION OF PD-1/PD-L1 AND VE1(BRAFP.V600E) IN PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS

    sneha tandon, Sheila Weitzman , Brooklyn Joyce, Bryan Maguire, Derek Stephens, James Whitlock, Cynthia Hawkins , Bo-Yee Ngan, Oussama Abla
    e2023035
    2023-04-27
    https://doi.org/10.4084/MJHID.2023.035
    1029
    PDF: 890
    HTML: 232
  • THE START-UP OF THE FIRST HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER IN THE IRAQI KURDISTAN: A CAPACITY-BUILDING COOPERATIVE PROJECT BY THE HIWA CANCER HOSPITAL, SULAYMANIYAH, AND THE ITALIAN AGENCY FOR DEVELOPMENT COOPERATION

    Ignazio Majolino
    e2017031
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.031
    2236
    PDF: 1000
    HTML: 2073
  • GREEK CONSENSUS ON CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENT

    Sotirios Sachanas, Theodoros Vassilakopoulos, Maria Angelopoulou, sotirios Papageorgiou, Emmanouil Spanoudakis, Maria Bouzani, Maria Dimou, Panagiotis Panagiotidis
    e2025014
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.014
    1316
    HTML: 119
    PDF: 855
  • CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment

    Ugo Testa, Elvira Pelosi, Dr. Germana Castelli
    e2024077
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.077
    1700
    PDF: 830
    HTML: 142
  • TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.

    Silvia F Costa, Jessica Ramos, Marjorie Vieira Batista
    e2013061
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.061
    2604
    PDF: 933
    HTML: 3597
  • TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS

    Luca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, Chiara Sarlo, Luigi Di Caprio, Concetta Ditto, Federica Giannotti, Daniela Nasso, Eleonora Ceresoli, Massimiliano Postorino, Marco Refrigeri, Sergio Amadori, Adriano Venditti
    e2013032
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.032
    2780
    PDF: 1002
    HTML: 5511
51 - 100 of 102 items << < 1 2 3 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy